Jeffrey E. Russel

Array ( [id] => 957438 [patent_doc_number] => RE038827 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2005-10-11 [patent_title] => 'Adhesive sealant composition' [patent_app_type] => reissue [patent_app_number] => 10/293989 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8090 [patent_no_of_claims] => 286 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038827.pdf [firstpage_image] =>[orig_patent_app_number] => 10293989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 988195 [patent_doc_number] => 06921750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => 'Analogs of parathyroid hormone' [patent_app_type] => utility [patent_app_number] => 10/289519 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16151 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921750.pdf [firstpage_image] =>[orig_patent_app_number] => 10289519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6673798 [patent_doc_number] => 20030059401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Composition and method for causing photodynamic damage to target cells' [patent_app_type] => new [patent_app_number] => 10/288617 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5331 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059401.pdf [firstpage_image] =>[orig_patent_app_number] => 10288617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861626 [patent_doc_number] => 20030092634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Novel compounds and compositions as protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/288103 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32486 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092634.pdf [firstpage_image] =>[orig_patent_app_number] => 10288103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1165516 [patent_doc_number] => 06759511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-06 [patent_title] => 'Compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same' [patent_app_type] => B2 [patent_app_number] => 10/284387 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6612 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759511.pdf [firstpage_image] =>[orig_patent_app_number] => 10284387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697261 [patent_doc_number] => 20030109455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'HEPTA-, OCTA-and nonapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/283550 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21471 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109455.pdf [firstpage_image] =>[orig_patent_app_number] => 10283550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963695 [patent_doc_number] => 06949507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-27 [patent_title] => 'Use of agents which bind G proteins for treating septic shock' [patent_app_type] => utility [patent_app_number] => 10/283675 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6317 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949507.pdf [firstpage_image] =>[orig_patent_app_number] => 10283675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7629733 [patent_doc_number] => 06818623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => 'Active hedgehog protein conjugate' [patent_app_type] => B2 [patent_app_number] => 10/278060 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10649 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818623.pdf [firstpage_image] =>[orig_patent_app_number] => 10278060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543140 [patent_doc_number] => 07166578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Orally administered peptides synergize statin activity' [patent_app_type] => utility [patent_app_number] => 10/273386 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25368 [patent_no_of_claims] => 127 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166578.pdf [firstpage_image] =>[orig_patent_app_number] => 10273386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669396 [patent_doc_number] => 20030114380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein' [patent_app_type] => new [patent_app_number] => 10/270707 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6992 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114380.pdf [firstpage_image] =>[orig_patent_app_number] => 10270707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6731037 [patent_doc_number] => 20030187227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Isolation of immunoglobulins' [patent_app_type] => new [patent_app_number] => 10/268667 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23886 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187227.pdf [firstpage_image] =>[orig_patent_app_number] => 10268667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847338 [patent_doc_number] => 20030166505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Neo-tryptophan' [patent_app_type] => new [patent_app_number] => 10/265099 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16367 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166505.pdf [firstpage_image] =>[orig_patent_app_number] => 10265099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683325 [patent_doc_number] => 20030119189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Method for delivery of molecules to intracellular targets' [patent_app_type] => new [patent_app_number] => 10/246441 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17944 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119189.pdf [firstpage_image] =>[orig_patent_app_number] => 10246441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809538 [patent_doc_number] => 20030199477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Use of gellable pharmaceutical compositions in periodontology' [patent_app_type] => new [patent_app_number] => 10/259366 [patent_app_country] => US [patent_app_date] => 2002-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4958 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199477.pdf [firstpage_image] =>[orig_patent_app_number] => 10259366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068790 [patent_doc_number] => 06844316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Inhibitors of dipeptidyl peptidase I' [patent_app_type] => utility [patent_app_number] => 10/236136 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11194 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844316.pdf [firstpage_image] =>[orig_patent_app_number] => 10236136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870542 [patent_doc_number] => 20030083232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith' [patent_app_type] => new [patent_app_number] => 10/235381 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19795 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083232.pdf [firstpage_image] =>[orig_patent_app_number] => 10235381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818212 [patent_doc_number] => 20030069170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith' [patent_app_type] => new [patent_app_number] => 10/235284 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30990 [patent_no_of_claims] => 130 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069170.pdf [firstpage_image] =>[orig_patent_app_number] => 10235284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674799 [patent_doc_number] => 20030060402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Novel cyclosporin galenic forms' [patent_app_type] => new [patent_app_number] => 10/234273 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14401 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060402.pdf [firstpage_image] =>[orig_patent_app_number] => 10234273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870095 [patent_doc_number] => 20030082784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same' [patent_app_type] => new [patent_app_number] => 10/233284 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3967 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082784.pdf [firstpage_image] =>[orig_patent_app_number] => 10233284 [rel_patent_id] =>[rel_patent_doc_number] =>)